EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus

Hanna Menschikowski iD, Christopher Bednar iD, Sabrina Kübel, Manuel Hermann, Larissa Bauer, Marco Thomas iD, Arne Cordsmeier, Armin Ensser iD

Viruses · 29.05.2024 · 16 (6) · 869

DOI: 10.3390/v16060869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 29.05.2024. Verfasst von Hanna Menschikowski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, …. Hauptthemen laut MEDLINE: T-Lymphocytes, Muromegalovirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus is a ubiquitous herpesvirus that, while latent in most individuals, poses a great risk to immunocompromised patients. In contrast to directly acting traditional antiviral drugs, such as ganciclovir, we aim to emulate a physiological infection control using T cells. For this, we constructed several bispecific T-cell engager (BiTE) constructs targeting different viral glycoproteins of the murine cytomegalovirus and evaluated them in vitro for their efficacy. To isolate the target specific effect without viral immune evasion, we established stable reporter cell lines expressing the viral target glycoprotein B, and the glycoprotein complexes gN-gM and gH-gL, as well as nano-luciferase (nLuc). First, we evaluated binding capacities using flow cytometry and established killing assays, measuring nLuc-release upon cell lysis. All BiTE constructs proved to be functional mediators for T-cell recruitment and will allow a proof of concept for this treatment option. This might pave the way for strikingly safer immunosuppression in vulnerable patient groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesMuromegalovirusAnimalsMiceHumansAntibodies, BispecificCell LineHerpesviridae InfectionsViral Envelope Proteins

Stichwörter der Autor:innen

BiTECMVT cellT-cell toxicitybispecificbispecific T-cell engagercytomegalovirusmurine cytomegalovirus

Substanzen

Antibodies, BispecificViral Envelope Proteins

Autor:innen und Institutionen

  • Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

ORCID-Profile: Hanna Menschikowski, Christopher Bednar, Marco Thomas, Armin Ensser

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Menschikowski, H., Bednar, C., Kübel, S., Hermann, M., Bauer, L., Thomas, M., Cordsmeier, A., & Ensser, A. (2024). Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus. Viruses, 16(6), 869. https://doi.org/10.3390/v16060869

Vancouver

Menschikowski H, Bednar C, Kübel S, Hermann M, Bauer L, Thomas M, et al. Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus. Viruses. 2024;16(6):869. doi:10.3390/v16060869

BibTeX
@article{Menschikowski2024,
  author = {Menschikowski, Hanna and Bednar, Christopher and Kübel, Sabrina and Hermann, Manuel and Bauer, Larissa and Thomas, Marco and Cordsmeier, Arne and Ensser, Armin},
  title = {Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {6},
  pages = {869},
  doi = {10.3390/v16060869}
}
Kostenlos starten →